Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma
NCT02590497Withdrawn
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Mar 2016
- Primary completion
- Oct 2017
01
Overview
Open-label, single-arm trial, sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoints: Correlation between the genetic and neuroimaging signature of glioblastoma and prognosis at Day 1, Diffusional kurtosis (DK) values at Day 1 and 1 more. Planned start Mar 2016; status: withdrawn.
Beyond the preview
Go deeper on NCT02590497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02590497.